-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Omada Health, Raises Price Target to $20

Benzinga·05/08/2026 15:40:00
Listen to the news
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $18 to $20.